TrialCell reports. Medicine2023

PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with BRPC/LAPC: A biomolecular exploratory, phase II trial.

Juan Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.